
Mark Rosenbaum
Examiner (ID: 6231, Phone: (571)272-4523 , Office: P/3725 )
| Most Active Art Unit | 3725 |
| Art Unit(s) | 3209, 3204, 3203, 3725, 3502, 3206, 3505, 2899, 3201, 3202, 3103 |
| Total Applications | 4526 |
| Issued Applications | 3830 |
| Pending Applications | 109 |
| Abandoned Applications | 597 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18815858
[patent_doc_number] => 20230390197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => MODULAR DENDRON MICELLES FOR COMBINATION IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 18/250065
[patent_app_country] => US
[patent_app_date] => 2021-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250065
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/250065 | MODULAR DENDRON MICELLES FOR COMBINATION IMMUNOTHERAPY | Oct 25, 2021 | Pending |
Array
(
[id] => 19947140
[patent_doc_number] => 12318478
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Risperidone or paliperidone implant formulation
[patent_app_type] => utility
[patent_app_number] => 17/498514
[patent_app_country] => US
[patent_app_date] => 2021-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 15102
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17498514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/498514 | Risperidone or paliperidone implant formulation | Oct 10, 2021 | Issued |
Array
(
[id] => 18842741
[patent_doc_number] => 20230405145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => IRON OXIDE NANOPARTICLE FOR SUPPRESSING DRUG-RESISTANT GENE FOR THE TREATMENT OF GLIOBLASTOMA
[patent_app_type] => utility
[patent_app_number] => 18/248139
[patent_app_country] => US
[patent_app_date] => 2021-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248139
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248139 | IRON OXIDE NANOPARTICLE FOR SUPPRESSING DRUG-RESISTANT GENE FOR THE TREATMENT OF GLIOBLASTOMA | Oct 5, 2021 | Pending |
Array
(
[id] => 17355217
[patent_doc_number] => 20220016013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => COMPOSITION COMPRISING AN ALKOXYSILANE, A FATTY ESTER AND A SILICONE, AND COSMETIC USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/491787
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491787
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/491787 | COMPOSITION COMPRISING AN ALKOXYSILANE, A FATTY ESTER AND A SILICONE, AND COSMETIC USE THEREOF | Sep 30, 2021 | Pending |
Array
(
[id] => 18859378
[patent_doc_number] => 20230413811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => TRIALKYL SULFONIUM CHLORIDES AS FUNGICIDES
[patent_app_type] => utility
[patent_app_number] => 18/029782
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029782
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029782 | TRIALKYL SULFONIUM CHLORIDES AS FUNGICIDES | Sep 30, 2021 | Pending |
Array
(
[id] => 18921227
[patent_doc_number] => 20240024231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => Hydrogel material
[patent_app_type] => utility
[patent_app_number] => 18/029927
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029927
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029927 | Hydrogel material | Sep 28, 2021 | Pending |
Array
(
[id] => 17412619
[patent_doc_number] => 20220047523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => COLOR-CHANGING ANTIBACTERIAL NANOFIBER
[patent_app_type] => utility
[patent_app_number] => 17/487285
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17487285
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/487285 | COLOR-CHANGING ANTIBACTERIAL NANOFIBER | Sep 27, 2021 | Pending |
Array
(
[id] => 18901246
[patent_doc_number] => 20240016731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => Drug Implants Containing Apalutamide and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 18/025611
[patent_app_country] => US
[patent_app_date] => 2021-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025611
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025611 | Drug Implants Containing Apalutamide and Methods of Use Thereof | Sep 26, 2021 | Pending |
Array
(
[id] => 18535925
[patent_doc_number] => 20230241011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => TREATMENTS OF DIABETIC ULCERS, RELATED COMPOSITIONS AND KITS
[patent_app_type] => utility
[patent_app_number] => 18/024509
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024509
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024509 | TREATMENTS OF DIABETIC ULCERS, RELATED COMPOSITIONS AND KITS | Sep 9, 2021 | Pending |
Array
(
[id] => 18043640
[patent_doc_number] => 11517573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-06
[patent_title] => Therapeutic compositions, combinations, and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/470471
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13817
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470471
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470471 | Therapeutic compositions, combinations, and methods of use | Sep 8, 2021 | Issued |
Array
(
[id] => 17298154
[patent_doc_number] => 20210393993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => HAND SANITIZERS WITH IMPROVED AESTHETICS AND SKIN-CONDITIONING TO ENCOURAGE COMPLIANCE WITH HAND HYGIENE GUIDELINES
[patent_app_type] => utility
[patent_app_number] => 17/465062
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465062
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/465062 | Hand sanitizers with improved aesthetics and skin-conditioning to encourage compliance with hand hygiene guidelines | Sep 1, 2021 | Issued |
Array
(
[id] => 17440831
[patent_doc_number] => 20220061336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => Natural Concentrated Composition for Killing and Repelling Pests
[patent_app_type] => utility
[patent_app_number] => 17/412189
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17412189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/412189 | Natural Concentrated Composition for Killing and Repelling Pests | Aug 24, 2021 | Abandoned |
Array
(
[id] => 17290800
[patent_doc_number] => 20210386639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => Foaming Topical Antimicrobial Cleaning Compositions
[patent_app_type] => utility
[patent_app_number] => 17/405462
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405462
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/405462 | Foaming Topical Antimicrobial Cleaning Compositions | Aug 17, 2021 | Abandoned |
Array
(
[id] => 18550838
[patent_doc_number] => 20230248838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => CENTRAL NERVOUS SYSTEM DELIVERY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
[patent_app_type] => utility
[patent_app_number] => 18/004633
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -69
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004633
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004633 | CENTRAL NERVOUS SYSTEM DELIVERY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS | Jul 29, 2021 | Pending |
Array
(
[id] => 17334555
[patent_doc_number] => 20220000886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/378458
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378458
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/378458 | Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same | Jul 15, 2021 | Issued |
Array
(
[id] => 18724355
[patent_doc_number] => 20230338497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => METHOD FOR PREPARING A VACCINE COMPOSITION FROM LYOPHILIZED ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 18/004980
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004980
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004980 | METHOD FOR PREPARING A VACCINE COMPOSITION FROM LYOPHILIZED ANTIGENS | Jul 7, 2021 | Pending |
Array
(
[id] => 17342006
[patent_doc_number] => 20220008337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => PHARMACEUTICAL LIQUID COMPOSITIONS OF MELOXICAM
[patent_app_type] => utility
[patent_app_number] => 17/368367
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368367 | PHARMACEUTICAL LIQUID COMPOSITIONS OF MELOXICAM | Jul 5, 2021 | Abandoned |
Array
(
[id] => 18201150
[patent_doc_number] => 11583521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Long-acting injection dosage form of beta 3 adrenoreceptor agonists
[patent_app_type] => utility
[patent_app_number] => 17/364469
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10577
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17364469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/364469 | Long-acting injection dosage form of beta 3 adrenoreceptor agonists | Jun 29, 2021 | Issued |
Array
(
[id] => 17503405
[patent_doc_number] => 20220096507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => Parenteral Pharmaceutical Composition Comprising Azacitidine or Decitabine in DMSO
[patent_app_type] => utility
[patent_app_number] => 17/423210
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423210
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423210 | Parenteral Pharmaceutical Composition Comprising Azacitidine or Decitabine in DMSO | Jun 28, 2021 | Abandoned |
Array
(
[id] => 17168625
[patent_doc_number] => 20210322295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => Cleansing Compositions
[patent_app_type] => utility
[patent_app_number] => 17/304578
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17304578
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/304578 | Cleansing compositions | Jun 22, 2021 | Issued |